Literature DB >> 393293

Failure of leucocyte-adherence-inhibition assays to discriminate between benign and malignant breast diseases.

B M Vose, R Hughes, G W Bazill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 393293      PMCID： PMC2010137          DOI： 10.1038/bjc.1979.292

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  11 in total

1.  Antigenic cross-reactivity between benign and malignant neoplasms of the human breast.

Authors:  F Avis; I Mosonov; G Haughton
Journal:  J Natl Cancer Inst       Date:  1974-04       Impact factor: 13.506

2.  Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.

Authors:  N Grosser; D M Thomson
Journal:  Cancer Res       Date:  1975-09       Impact factor: 12.701

3.  Leukocyte-adherence inhibition: a specific assay of cell-mediated immunity dependent on lymphokine-mediated collaboration between T lymphocytes.

Authors:  A E Powell; A M Sloss; R N Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay.

Authors:  G B Cannon; J L McCoy; L J Jerome; R Reddick; C Alford; V Tinley; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1978-11       Impact factor: 13.506

5.  [Immunodiagnostic aspects of breast cancer (author's transl)].

Authors:  D Fritze; J Fritze; M Kaufmann; P Drings
Journal:  Dtsch Med Wochenschr       Date:  1978-02-17       Impact factor: 0.628

6.  Leukocyte migration inhibition in human pulmonary neoplasia.

Authors:  B M Vose; I Kimber; M Moore
Journal:  J Natl Cancer Inst       Date:  1977-03       Impact factor: 13.506

7.  Evaluation of leucocyte adherence inhibition in hepatocellular carcinoma.

Authors:  G M Dusheiko; M C Kew; A R Rabson
Journal:  Br J Cancer       Date:  1979-09       Impact factor: 7.640

8.  A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.

Authors:  R O'Connor; J K MacFarlane; D Murray; D M Thomson
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

9.  The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.

Authors:  M Lopez; R O'Connor; J K MacFarlane; D M Thomson
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

10.  Leucocyte-migration-inhibition test in patients with colorectal cancer: clinicopathological correlations.

Authors:  P Burtin; C Pinset; E Chany; M C Fondaneche; G Chavanel
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640
View more
  2 in total

1.  Leukocyte adherence inhibition in patients with nonmalignant disorders of the colon and colorectal cancer.

Authors:  B Tank; R L Marquet; E Vennemans; D L Westbroek
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

2.  Circulating anti-tumor and autoantibodies in breast carcinoma: relationship to stage and prognosis.

Authors:  Y T Lee; K M Sheikh; F P Quismorio; G J Friou
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.